Skip to main content

Table 3 Cross-sectional associations between CRP and metabolic health outcomes during pregnancy and in the postpartum

From: C-reactive protein during pregnancy and in the early postpartum predicts adverse metabolic health outcomes at 1 year postpartum in women with gestational diabetes

Variable

Model 1

Model 2

Model 3

β

95% CI

p value

β

95% CI

p value

β

95% CI

p value

CRP at 28–32 weeks GA

Insulin resistance and secretion variables during pregnancy

 Weight (kg)bc

1.68

1.18, 2.17

 < 0.001

1.67

1.2, 2.20

 < 0.001

NA

NA

NA

 Body fat (kg)c

1.24

0.94, 1.55

 < 0.001

0.28

0.15, 0.41

 < 0.001

NA

NA

NA

 MetS-BMI, yesa

1.12

1.03, 1.22

0.006

1.02

0.90, 1.11

0.965

0.98

0.87, 1.09

0.772

 Fasting glucose (mmol/l)

0.02

0.008, 0.04

0.004

0.02

0.009, 0.04

0.004

0.06

− 0.02, 0.02

0.995

 HbA1c (%)

0.01

0.004, 0.02

0.007

0.01

0.007, 0.03

0.001

0.09

− 0.03, 0.02

0.164

 HOMA-IR

0.16

0.05, 0.26

0.003

0.15

0.05, 0.26

0.004

0.002

-0.08, 0.09

0.960

 HOMA-B

1.99

0.69, 3.2

0.003

0.21

− 1.06, 1.48

0.742

− 0.16

− 1.41, 1.01

0.792

CRP at 6–8 weeks pp

Insulin resistance and secretion variables at 6–8 weeks postpartum

 Weight (kg)bc

1.48

0.88, 2.09

 < 0.001

1.48

0.87, 2.08

 < 0.001

NA

NA

NA

 Body fat (kg)c

1.06

0.66, 1.45

 < 0.001

0.16

0.03, 0.29

0.015

NA

NA

NA

 MetS-BMI, yesa

1.10

0.97, 1.25

0.107

0.98

0.83, 1.15

0.818

0.92

0.76, 1.11

0.421

 Fasting glucose (mmol/l)

0.01

− 0.01, 0.04

0.228

− 0.005

− 0.03, 0.02

0.686

− 0.006

− 0.03, 0.02

0.665

 HbA1c (%)

0.01

− 0.007, 0.03

0.060

0.02

0.0005, 0.36

0.043

0.01

0.001, 0.03

0.036

 HOMA-IR

0.11

0.03, 0.19

0.005

0.04

− 0.03, 0.12

0.306

0.03

− 0.04, 0.11

0.383

 MATSUDA index

− 0.38

− 0.56, − 0.19

 < 0.001

− 0.19

− 0.37, − 0.02

0.024

− 0.18

− 0.35, − 0.01

0.038

 ISSI-2

− 0.06

− 0.11, − 0.02

0.009

− 0.03

− 0.08, 0.02

0.226

− 0.03

− 0.08, 0.02

0.284

 AUCins/glu

0.01

0.006, 0.03

0.002

0.09

− 0.007, 0.01

0.070

0.08

− 0.01, 0.02

0.106

 HOMA-B

1.59

0.41, 2.76

0.008

0.57

− 0.57, 1.72

0.325

0.49

− 0.67, 1.65

0.409

CRP at 1-year pp

Insulin resistance and secretion variables at 1-year postpartum

 Weight (kg)bc

1.59

0.99, 2.19

 < 0.001

1.58

0.98, 2.19

 < 0.001

NA

NA

NA

 Body fat (kg)c

1.23

0.84, 1.61

 < 0.001

0.25

0.13, 0.36

 < 0.001

NA

NA

NA

 MetS-BMI, yesa

1.20

1.08, 1.33

 < 0.001

1.12

0.98, 1.27

0.073

1.09

0.95, 1.24

0.198

 MetS-WC, yesa

1.15

1.05, 1.26

0.002

1.09

0.98, 1.21

0.098

1.07

0.96, 1.18

0.183

 Fasting glucose (mmol/l)

0.02

0.003, 0.05

0.027

0.01

− 0.009, 0.04

0.211

0.02

− 0.01, 0.045

0.232

 HbA1c (%)

0.002

− 0.02, 0.03

0.808

− 0.07

− 0.03, 0.02

0.546

− 0.01

− 0.04, 0.01

0.364

 HOMA-IR

0.19

0.09, 0.28

 < 0.001

0.05

− 0.03, 0.13

0.238

0.03

− 0.06, 0.12

0.546

 MATSUDA index

− 0.24

− 0.36, − 0.12

 < 0.001

− 0.07

− 0.18, 0.04

0.214

− 0.04

− 0.16, 0.07

0.439

 ISSI-2

− 0.05

− 0.08, − 0.01

0.014

− 0.01

− 0.05, 0.02

0.547

− 0.07

− 0.49, 0.35

0.739

 AUCins/glu

0.02

0.008, 0.03

0.001

0.07

0.03, 0.18

0.195

0.006

− 0.006, 0.01

0.322

 HOMA-B

2.13

0.85, 3.40

0.001

0.20

− 0.95, 1.35

0.729

− 0.20

− 1.39, 0.97

0.726

  1. CRP denotes C-reactive protein; GA denotes gestational age; MetS denote metabolic syndrome; BMI denotes Body Mass Index; Mets-WC denotes metabolic syndrome based on waist circumference; pp denotes postpartum; NA denoted not applicable; HbA1c denotes glycated hemoglobin; HOMA-IR denotes Homeostatic Model Assessment for Insulin Resistance; ISSI-2 denotes; Insulin Secretion-Sensitivity Index-2; AUCins/glu denotes Area under the Curve; HOMA-B denotes HOMA of b-cell index.
  2. Model 1: Adjusted for group allocation. Model 2: Adjusted for group allocation, gestational age, age, previous history of GDM, family history of GDM, breastfeeding, weight at prediction time point. Model 3: adjusted for group allocation, gestational age, age, previous history of GDM, family history of GDM, breastfeeding, body fat at the prediction time point.
  3. aEstimates are from logistic regression analyses (Odds ratio and 95% CI). MetS-WC is not relevant in pregnancy and too early to assess in the early pp
  4. For these variables, the associations were not adjusted for bweight or cbody fat (additionally adjusted for age).
  5. Bold p-values indicate significant p-values